American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Objective analysis and clinical significance of the spatial tumor-infiltrating lymphocyte patterns in non-small cell lung cancer
    Journal Article

    Lopez de Rodas, M.; Wang, Y.; Peng, G.; Gu, J.; Mino-Kenudson, M.; Riess, J. W.; Velcheti, V.; Hellmann, M.; Gainor, J. F.; Zhao, H.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Phase I study of ORIC-101, a glucocorticoid receptor antagonist, in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer progressing on enzalutamide
    Journal Article

    Abida, W.; Hahn, A. W.; Shore, N.; Agarwal, N.; Sieber, P.; Smith, M. R.; Dorff, T.; Monk, P.; Rettig, M.; Patel, R.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • PD-1 expression on intratumoral regulatory T cells is associated with lack of benefit from anti-PD-1 therapy in metastatic clear-cell renal cell carcinoma patients
    Journal Article

    Denize, T.; Jegede, O. A.; Matar, S.; Al Ahmar, N.; West, D. J.; Walton, E.; Bagheri, A. S.; Savla, V.; Laimon, Y. N.; Gupta, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase Ib study of the DNA-PK inhibitor peposertib combined with neoadjuvant chemoradiation in patients with locally advanced rectal cancer
    Journal Article

    Romesser, P. B.; Capdevila, J.; Garcia-Carbonero, R.; Philip, T.; Martos, C. F.; Tuli, R.; Rodriguez-Gutierrez, A.; Kuipers, M.; Becker, A.; Coenen-Stass, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Phase Ia/b study of giredestrant ± palbociclib and ± luteinizing hormone-releasing hormone agonists in estrogen receptor-positive, HER2-negative, locally advanced/metastatic breast cancer
    Journal Article

    Jhaveri, K. L.; Bellet, M.; Turner, N. C.; Loi, S.; Bardia, A.; Boni, V.; Sohn, J.; Neilan, T. G.; Villanueva-Vázquez, R.; Kabos, P.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-Mérida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Aneuploidy landscape in precursors of ovarian cancer
    Journal Article

    Wang, Y.; Douville, C.; Chien, Y. W.; Wang, B. G.; Chen, C. L.; Pinto, A.; Smith, S. A.; Drapkin, R.; Chui, M. H.; Numan, T.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Tumor volume growth as surrogate endpoint in IDH-mt glioma — Response
    Correspondence

    Bhatia, A.; Moreno, R.; Reiner, A. S.; Nandakumar, S.; Walch, H. S.; Malani, R.; Panageas, K. S.; Mellinghoff, I. K.; Bale, T. A.; Young, R. J.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Development of resistance to type II JAK2 inhibitors in MPN depends on AXL kinase and is targetable
    Journal Article

    Codilupi, T.; Szybinski, J.; Arunasalam, S.; Jungius, S.; Dunbar, A. C.; Stivala, S.; Brkic, S.; Albrecht, C.; Vokalova, L.; Yang, J. L.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Development of a practical nomogram for personalized anemia management in patients treated with ataxia telangiectasia and Rad3-related inhibitor camonsertib
    Journal Article

    Rosen, E.; Yap, T. A.; Lee, E. K.; Højgaard, M.; Mettu, N. B.; Lheureux, S.; Carneiro, B. A.; Plummer, R.; Fretland, A. J.; Ulanet, D.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: